Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study Between Chloroquine and Hydroxychloroquine as Therapeutic Modalities for Children and Adolescents With Proliferative Lupus Nephritis

NCT03687905 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT03687905
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03687905 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study Between Chloroquine and Hydroxychloroquine as Therapeutic Modalities for Children and Adolescents With Proliferative Lupus Nephritis
Lead sponsor
Tanta University
Phase
Observational
Overall status
Unknown status
Start date
September 18, 2018
Completion date
September 30, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chloroquine retinopathy, proliferative nephritis